A phase 2B, 24-week study evaluating the efficacy and safety of two doses of zonisamide sr/bupropion sr combination therapy in overweight and obese subjects

Authors
Category Primary study
JournalDiabetes
Year 2010
This article has no abstract
Epistemonikos ID: a9c677f138e2b981c02c4b52f2a173e9870813ab
First added on: Feb 06, 2025